Related Experiment Videos
Stevens-Johnson syndrome during an immunosuppressive therapy with cyclophosphamide and prednisone
Klinische Padiatrie
|September 1, 1985
Insights
Corticosteroids may not be effective for treating severe Stevens-Johnson syndrome. A 12-year-old boy developed this condition while on immunosuppressive therapy, questioning the standard treatment approach.
Area of Science:
- Pediatric Nephrology
- Dermatology
- Immunology
Background:
- Stevens-Johnson syndrome (SJS) is a severe mucocutaneous reaction, often treated with corticosteroids.
- Nephrotic syndrome is a kidney disorder requiring immunosuppressive therapy, such as prednisone and cyclophosphamide.
Observation:
- A 12-year-old boy developed SJS during immunosuppressive treatment for relapsing, steroid-dependent nephrotic syndrome.
- Common etiologic factors for erythema multiforme, a related condition, were ruled out.
Findings:
- The patient's SJS developed despite, or possibly because of, ongoing immunosuppressive therapy.
- The efficacy of corticosteroid treatment for SJS in this context is questionable.
Implications:
- This case challenges the routine use of corticosteroids in severe SJS, particularly in patients on concurrent immunosuppression.
- Further research is needed to understand the role of corticosteroids and immunosuppressive agents in SJS pathogenesis and treatment.
- Alternative therapeutic strategies for SJS in immunocompromised patients may need to be explored.
Abstract:
Corticosteroids are often recommended for the treatment of severe Stevens-Johnson syndrome. We report about a 12 years old boy, who developed this syndrome during an immunosuppressive therapy with prednisone and cyclophosphamide for a frequent relapsing, steroid-dependent nephrotic syndrome. Most of the commonly mentioned etiologic factors for erythema exudativum multiforme could be excluded. The usefulness of corticosteroids for the therapy seems to be doubtful.